We plan to leverage the full power of our platform technology towards the development of
novel targeted therapeutics for major cancers such as lung, bladder, pancreas, liver, ovarian,
colon, breast, and prostate.
Systemic Fungul Infection
We plan to partner with Diagnostics Companies towards the development of our technology
concerning diagnositics of systemic fungal infection